| Predicting liver metastasis in colorectal cancer patients using routine biochemical tests enhanced by machine learning. | Erdat EC, Yalciner M, Kavak EE, Dilli I, Cakmak Oksuzoglu OB, Akbulut H, Utkan G. | Clin Transl Oncol. 2025 Jan 17. doi: 10.1007/s12094-025-03996-w. | 40676388 |
| The Effect of Metformin Usage in Patients With Metastatic Colorectal Cancer Receiving First-line Systemic Therapy. | Erdat EC, Yalciner M, Geris Y, Utkan G. | In Vivo. 2025 Jan-Feb;39(4):2349-2356. doi: 10.21873/invivo.14032. | 40579038 |
| Low-Density Lipoprotein (LDL) is Associated with Earlier Progression in Synchronous Metastatic Colorectal Cancer Treated without Curative Intent. | Akkus E, Öksüz NE, Utkan G. | J Gastrointest Cancer. 2025 Feb 5;56(1):58. doi: 10.1007/s12029-025-01166-3. | 39907838 |
| Combined preoperative and post-adjuvant-chemotherapy carcinoembryonic antigen levels are prognostic for early recurrence and survival in stage III colon cancer. | Akkus E, Karaoğlan BB, Akçadağ B, Bahçekapılı B, Akyol C, Utkan G. | Am J Surg. 2025 May;243:116256. doi: 10.1016/j.amjsurg.2025.116256. | 40015199 |
| Stage-specific characterization of 'early-onset colorectal cancer': Localized and synchronous metastatic disease. | Akkus E, Karaoğlan BB, Kayaalp M, Turmuş U, Akyol C, Utkan G. | Int J Cancer. 2025 Jun 15;156(12):2340-2351. doi: 10.1002/ijc.35336. | 39887374 |
| Real-world treatment compliance and outcomes in adult patients with localized Ewing sarcoma: A single-institution retrospective study. | Kalaci E, Köksoy EB, Akbiyik I, Dursun B, Utkan G. | Medicine (Baltimore). 2025 Jan 18;104(29):e43405. doi: 10.1097/MD.0000000000043405. | 40696651 |
| TARE-Induced Pan-Immune Inflammation Value as a Prognostic Biomarker in Liver-Dominant Metastatic Colorectal Cancer. | Dursun B, Demir B, Öksüz NE, Soydal Ç, Utkan G. | J Clin Med. 2025 Jan 11;14(14):4927. doi: 10.3390/jcm14144927. | 40725620 |
| Lymph Node Ratio (LNR) Discriminates Prognostication in pN1a-b and pN2 Stage-III Colon Cancer. | Akkus E, Kayaalp M, Karaoğlan BB, Akyol C, Utkan G. | J Cancer. 2025 Jan 1;16(4):1032-1039. doi: 10.7150/jca.104336. | 39895795 |
| The Effect of Statin Usage on Survival in Metastatic Colorectal Cancer Patients Receiving Regorafenib. | Erdat EC, Kavak EE, Yalciner M, Utkan G. | In Vivo. 2024 Nov-Dec;38(6):2921-2927. doi: 10.21873/invivo.13774. | 39477441 |
| Treatment approaches and survival outcomes in elderly colorectal cancer patients: a single-center comparative study. | Karaoğlan BB, Akkuş E, Kayaalp M, Akyol C, Erkek AB, Akbulut H, Utkan G. | Clin Transl Oncol. 2024 Oct 28. doi: 10.1007/s12094-024-03758-0. | 39467964 |
| Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis. | Karaoğlan BB, Öztürk İ, Akyol C, Savaş B, Utkan G. | J Gastrointest Cancer. 2024 Oct 31;56(1):14. doi: 10.1007/s12029-024-01135-2. | 39480587 |
| Impact of low sodium values on survival outcomes of patients with cancer receiving immune checkpoint inhibitors. | Karaoğlan BB, Yekedüz E, Yazgan SC, Mocan EE, Köksoy EB, Yaşar HA, Şenler FÇ, Utkan G, Demirkazık A, Akbulut H, Ürün Y. | Immunotherapy. 2024;16(12):821-828. doi: 10.1080/1750743X.2024.2370231. | 39016058 |
| Types and Rates of COVID-19 Vaccination in Patients With Newly Diagnosed Microsatellite Stable and Instable Non-Metastatic Colon Cancer. | Akkus E, Karaoglan B, Akyol C, Ünal AE, Kuzu MA, Savaş B, Utkan G. | Cureus. 2024 Jun 6;16(6):e61780. doi: 10.7759/cureus.61780. | 38975417 |
| Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG). | Yasar HA, Aktas BY, Ucar G, Goksu SS, Bilgetekin I, Cakar B, Sakin A, Ates O, Basoglu T, Arslan C, Demiray AG, Paydas S, Cicin I, Sendur MAN, Karadurmus N, Kosku H, Uner A, Yumuk PF, Utkan G, Kefeli U, Tanriverdi O, Cinkir H, Gumusay O, Turhal NS, Menekse S, Kut E, Beypinar I, Saklar T, Demir H, Yekeduz E, Kilickap S, Erman M, Urun Y. | Clin Genitourin Cancer. 2024 Jun;22(3):102077. doi: 10.1016/j.clgc.2024.102077. | 38626660 |
| Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer. | Alkan A, Mızrak D, Yaşar A, Karcı E, Köksoy EB, Ürün M, Özyurt N, Kuştaş AA, Kütük T, Ürün Y, Şenler FÇ, Akyürek S, Utkan G, Demirkazık A, Gökçe ŞÇ, Akbulut H. | J Cancer Res Ther. 2024 Apr 1;20(3):913-917. doi: 10.4103/jcrt.jcrt_1009_20. | 39023597 |
| Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities. | Karaoğlan BB, Öz DK, Araz MS, Akyol C, Utkan G. | Curr Oncol Rep. 2024 Jul;26(7):791-803. doi: 10.1007/s11912-024-01548-z. | 38776011 |
| Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study. | Yaşar S, Yılmaz F, Utkan G, Algın E, Bayram D, Tamam S, Öksüzoğlu ÖBÇ, İlhan A, Erdat EC, Ünal AE, Yalçın Ş. | Ann Surg Oncol. 2024 Sep;31(9):6228-6236. doi: 10.1245/s10434-024-15506-3. | 38806763 |
| Distributions and prognostic effects of ABO/Rh blood groups in patients with HER2/neu positive gastric and gastroesophageal junction cancer. | Dogan I, Gurbuz M, Aydin E, Karabulut S, Tastekin D, Utkan G. | J Cancer Res Ther. 2023 Jan 1;19(Suppl 2):S747-S751. doi: 10.4103/jcrt.jcrt_1520_22. | 38384050 |
| Exploring the connection between microsatellite instability and inflammatory indicators in cancers. | Karaoğlan BB, Savaş B, Utkan G, Ürün Y. | Future Oncol. 2024 Jan;20(2):95-105. doi: 10.2217/fon-2023-0695. | 38318682 |
| Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients. | Eylemer Mocan E, Yekedüz E, Karataş G, Yazgan SC, Köksoy EB, Çay Şenler F, Utkan G, Demirkazik A, Akbulut H, Ürün Y. | Anticancer Drugs. 2024 Feb 1;35(2):190-194. doi: 10.1097/CAD.0000000000001498. | 38018837 |
| Relationship Between ABO Blood Group and Microsatellite Instability in Colorectal Cancer: A Retrospective Single-Center Study. | Karaoglan BB, Akyol C, Unal AE, Kuzu A, Savaş B, Utkan G. | J Gastrointest Cancer. 2024 Mar;55(1):281-286. doi: 10.1007/s12029-023-00958-9. | 37414939 |
| Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study. | Benlice C, Koc MA, Gulcu B, Bilgin IA, Akyol C, Baca B, Ozturk E, Guney Y, Utkan G, Er O, Agaoglu F, Yildirim I, Avci N, Elhan AH, Kuzu MA. | Dis Colon Rectum. 2023 May 1;66(5):681-690. doi: 10.1097/DCR.0000000000002646. | 36856669 |
| Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study. | Yekedüz E, Özbay MF, Çağlayan D, Yıldırım A, Erol C, Yıldırım HÇ, Tunç S, Özyurt N, Özdemir F, Şendur MAN, Işıkdoğan A, Kılıçkap S, Ürün Y, Yalçın Ş, Artaç M, Coşkun HŞ, Utkan G. | Eur J Clin Pharmacol. 2022 Dec;78(12):1973-1979. doi: 10.1007/s00228-022-03403-1. | 36266366 |
| Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRC. | Erdat EC, Koksoy EB, Utkan G. | J Gastrointest Cancer. 2023 Sep;54(3):897-902. doi: 10.1007/s12029-022-00890-4. | 36401084 |
| Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors. | Yekedüz E, Köksoy EB, Yazgan SC, Karataş G, Şenler FÇ, Utkan G, Akbulut H, Demirkazik A, Ürün Y. | Anticancer Drugs. 2022 Nov 1;33(10):1145-1149. doi: 10.1097/CAD.0000000000001354. | 35946564 |
| Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors. | Yazgan SC, Yekedüz E, Utkan G, Ürün Y. | Prostate. 2022 Nov;82(15):1456-1461. doi: 10.1002/pros.24419. | 35899494 |
| The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer. | Gürbüz M, Doğan İ, Akkuş E, Özakıncı H, Kubilay Tolunay P, Kalacı E, Bağlan T, Köksoy EB, Ceyhan K, Dizbay Sak S, Aydıner A, Demirkazık A, Utkan G. | Tuberk Toraks. 2022 Jun;70(2):132-140. doi: 10.5578/tt.20229803. | 35785877 |
| Genomic Landscape of Actionable Mutations in Primary and Metastatic Tissues of Colon Adenocarcinoma. | Yekedüz E, Akbulut H, Utkan G, Ürün Y. | Cureus. 2022 Apr 16;14(4):e24175. doi: 10.7759/cureus.24175. | 35592200 |
| The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib. | Yekedüz E, Aktaş EG, Köksoy EB, Doğan N, Ürün Y, Utkan G. | Future Oncol. 2022 Mar;18(9):1067-1076. doi: 10.2217/fon-2021-1182. | 35109668 |
| Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors. | Yekedüz E, Utkan G, Ürün Y. | Future Oncol. 2022 Feb;18(4):413-416. doi: 10.2217/fon-2021-1513. | 35018793 |
| Response to letter entitled: Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19. | Yekedüz E, Utkan G, Ürün Y. | Eur J Cancer. 2021 Jul;152:248-249. doi: 10.1016/j.ejca.2021.04.010. | 34016491 |
| The effect of primary tumour resection on patients with synchronous metastatic colorectal cancer treated with cetuximab-containing regimens. | Sertesen E, Yekedüz E, Köksoy EB, Ürün Y, Erkek AB, Demirci S, Ünal AE, Utkan G. | ANZ J Surg. 2023 Apr;93(4):945-950. doi: 10.1111/ans.18117. | 36259228 |
| Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data. | Gürbüz M, Doğan İ, Akkuş E, Ermiş H, Utkan G, Vatansever S, Taş F. | Dermatol Ther. 2021 Nov;34(6):e15122. doi: 10.1111/dth.15122. | 34478210 |
| Adjuvant Treatment of Gastric Cancer in the D2 Dissection Era: A Real-life Experience from a Multicenter Retrospective Cohort Study. | Yekedüz E, Doğan İ, Birgi SD, Keskin M, Karaman Ş, Utkan G, Karabulut S, Bayar S, Akbulut H, Demirci S, Akyürek S, Ürün Y. | Euroasian J Hepatogastroenterol. 2021 Jul-Dec;11(2):51-58. doi: 10.5005/jp-journals-10018-1343. | 34786357 |
| Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study. | Yekedüz E, Dogan İ, Kaya DM, Özgür İ, Utkan G, Vatansever S, Demirci S, Akbulut H, Ürün Y. | J Gastrointest Cancer. 2022 Dec;53(4):870-879. doi: 10.1007/s12029-021-00769-w. | 34845631 |
| Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors. | Yekedüz E, Trapani D, Xu W, de Vries EGE, Labaki C, Gyawali B, Gulati S, Nabhan C, Utkan G, Curigliano G, Choueiri TK, Ürün Y. | Int J Cancer. 2021 Oct 1;149(7):1455-1462. doi: 10.1002/ijc.33708. | 34124786 |
| In the Age of Immunotherapy, How Can We Translate the CARMENA Results into Practice? | Yekedüz E, Süer E, Utkan G, Baltacı S, Ürün Y. | Eur Urol Oncol. 2021 Jun;4(3):515-516. doi: 10.1016/j.euo.2021.02.009. | 33714722 |
| Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? | Yekedüz E, Utkan G, Ürün Y. | J Oncol Pharm Pract. 2021 Mar;27(2):450-452. doi: 10.1177/1078155220988753. | 33470163 |
| Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same? | Yekedüz E, Utkan G, Kanesvaran R, Ürün Y. | Prostate Int. 2021 Mar;9(1):1-5. doi: 10.1016/j.prnil.2020.03.002. | 33912507 |
| Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis. | Bakouny Z, Yekedüz E, Braun DA, Berchuck JE, Hirsch L, Utkan G, Lee Y, Trinh QD, Choueiri TK, Ürün Y. | Crit Rev Oncol Hematol. 2021 Oct;166:103463. doi: 10.1016/j.critrevonc.2021.103463. | 34461269 |
| mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors. | Yekedüz E, Ayasun R, Köksoy EB, Utkan G, Ürün Y, Akbulut H. | Future Virol. 2021 Aug:10.2217/fvl-2021-0166. doi: 10.2217/fvl-2021-0166. | 34531922 |
| ctDNA as a prognostic factor in operable colon cancer patients: a systematic review and meta-analysis. | Yekedüz E, Köksoy EB, Akbulut H, Ürün Y, Utkan G. | Future Oncol. 2021 Jan;17(3):349-357. doi: 10.2217/fon-2020-0671. | 33356539 |
| A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19. | Yekedüz E, Utkan G, Ürün Y. | Eur J Cancer. 2020 Dec;141:92-104. doi: 10.1016/j.ejca.2020.09.028. | 33130550 |
| A clinical dilemma amid COVID-19 pandemic: missed or encountered diagnosis of cancer? | Yekedüz E, Karcıoğlu AM, Utkan G, Ürün Y. | Future Oncol. 2020 Sep;16(25):1879-1881. doi: 10.2217/fon-2020-0501. | 32564611 |
| Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab. | Yekedüz E, Dursun B, Aydın GÇ, Yazgan SC, Öztürk HH, Azap A, Utkan G, Ürün Y. | J Oncol Pharm Pract. 2020 Jul;26(5):1289-1294. doi: 10.1177/1078155220924084. | 32423324 |
| A systematic review: Role of systemic therapy on treatment and prevention of brain metastasis in renal cell carcinoma. | Yekedüz E, Arzu Yaşar H, Utkan G, Ürün Y. | J Oncol Pharm Pract. 2020 Jun;26(4):972-981. doi: 10.1177/1078155220905648. | 32098554 |
| Sweet's syndrome under ipilimumab therapy and a brief comparison of the cases in literature. | Yaşar HA, Akkus E, Heper A, Akay BN, Urun Y, Utkan G. | J Oncol Pharm Pract. 2020 Oct;26(7):1762-1764. doi: 10.1177/1078155220906885. | 32089071 |
| Intense ¹⁸F-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy. | Soydal Ç, Akkuş P, Araz M, Utkan G. | Mol Imaging Radionucl Ther. 2020 Apr 29;29(2):79-81. doi: 10.4274/mirt.galenos.2019.40469. | 32368879 |
| Prevalence, etiology and risk factors of anemia in patients with newly diagnosed cancer. | Kenar G, Köksoy EB, Ürün Y, Utkan G. | Support Care Cancer. 2020 Nov;28(11):5235-5242. doi: 10.1007/s00520-020-05336-w. | 32086566 |
| The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer. | Yasar HA, Bir Yucel K, Arslan C, Ucar G, Karakaya S, Bilgin B, Taban H, Kucukarda A, Erturk I, Hızal M, Yıldız B, Yıldırım N, Demirci U, Sendur MA, Utkan G, Kılıckap S, Cicin I, Karadurmus N, Ürün Y. | J Oncol Pharm Pract. 2020 Jul;26(5):1110-1116. doi: 10.1177/1078155219883004. | 31653193 |
| Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospective analysis. | Ergun Y, Ozdemir NY, Guner EK, Esin E, Sendur MA, Koksoy EB, Demirci NS, Eren T, Dede I, Sezer A, Engin H, Oksuzoglu B, Yalcin B, Utkan G, Zengin N, Urun Y. | J BUON. 2018 Dec;23(7):116-121. | 30722120 |
| Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study. | Urun Y, Yasar HA, Turna H, Esin E, Sedef AM, Alkan A, Oksuzoglu B, Ozdemir N, Sendur MN, Sezer A, Kılıckap S, Utkan G, Akman T, Akbulut H, Celik I, Abalı H. | J Oncol Pharm Pract. 2019 Oct;25(7):1658-1664. doi: 10.1177/1078155218805539. | 30400750 |
| Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study. | Arzu Yaşar H, Turna H, Esin E, Murat Sedef A, Alkan A, Oksuzoglu B, Ozdemir N, Sendur MN, Sezer A, Kılıckap S, Utkan G, Akbulut H, Celik I, Abalı H, Urun Y. | J Oncol Pharm Pract. 2020 Mar;26(2):267-272. doi: 10.1177/1078155219840796. | 30924738 |
| Diagnostic serum vitamin D level is not a reliable prognostic factor for resectable breast cancer. | Mizrak Kaya D, Ozturk B, Kubilay P, Onur H, Utkan G, Cay Senler F, Alkan A, Yerlikaya H, Koksoy EB, Karci E, Demirkazik A, Akbulut H, Icli F. | Future Oncol. 2018 Jun;14(15):1461-1467. doi: 10.2217/fon-2017-0608. | 29741392 |
| Vaccination in oncology practice and predictors. | Alkan A, Karcı E, Yaşar A, Tuncay G, Köksoy EB, Ürün M, Şenler FÇ, Demirkazık A, Utkan G, Akbulut H, Ürün Y. | Support Care Cancer. 2017 Sep;25(9):2677-2682. doi: 10.1007/s00520-017-3675-y. | 28331981 |
| The significance of serum leptin level in patients with early stage nonsmall cell lung cancer. | Karatas F, Yalcin B, Sahin S, Akbulut H, Utkan G, Demirkazik A, Icli F. | J Cancer Res Ther. 2017 Apr-Jun;13(2):204-207. doi: 10.4103/0973-1482.196859. | 28643734 |
| Radiation-Induced Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia. | Alkan A, Kütük T, Karcı E, Yaşar A, Hiçsönmez A, Utkan G. | Turk J Haematol. 2016 Sep 5;33(3):248-50. doi: 10.4274/tjh.2015.0259. | 27093891 |
| Widespread Metastatic Prostate Carcinoma Shown by 68Ga-PSMA PET/CT. | Soydal C, Ozkan E, Yerlikaya H, Utkan G, Kucuk ON. | Clin Nucl Med. 2016 Jun;41(6):e294-5. doi: 10.1097/RLU.0000000000001176. | 26909710 |
| Sweet Syndrome After Autologous Stem Cell Transplant. | Alkan A, İdemen C, Okçu Heper A, Utkan G. | Exp Clin Transplant. 2016 Feb;14(1):109-11. doi: 10.6002/ect.2014.0073. | 25748978 |
| Medication errors in chemotherapy preparation and administration: a survey conducted among oncology nurses in Turkey. | Ulas A, Silay K, Akinci S, Dede DS, Akinci MB, Sendur MA, Cubukcu E, Coskun HS, Degirmenci M, Utkan G, Ozdemir N, Isikdogan A, Buyukcelik A, Inanc M, Bilici A, Odabasi H, Cihan S, Avci N, Yalcin B. | Asian Pac J Cancer Prev. 2015;16(5):1699-705. doi: 10.7314/apjcp.2015.16.5.1699. | 25773812 |
| The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer. | Ürun Y, Utkan G, Yalcin B, Akbulut H, Onur H, Oztuna DG, Şenler FC, Demirkazık A, İçli F. | Exp Oncol. 2015 Mar;37(1):53-7. | 25804233 |
| Lower folate levels in gastric cancer: is it a cause or a result? | Alkan A, Mızrak D, Utkan G. | World J Gastroenterol. 2015 Apr 7;21(13):4101-2. doi: 10.3748/wjg.v21.i13.4101. | 25852300 |
| First-line crizotinib in ALK-positive lung cancer. | Alkan A, Köksoy EB, Utkan G. | N Engl J Med. 2015 Feb 19;372(8):781-2. doi: 10.1056/NEJMc1415973. | 25693023 |
| The clinicopathological characteristics with long-term outcomes in malignant mesothelioma. | Dogan M, Utkan G, Hocazade C, Uncu D, Toptas S, Ozdemir N, Zengin N, Icli F. | Med Oncol. 2014 Oct;31(10):232. doi: 10.1007/s12032-014-0232-0. | 25208819 |
| Intraabdominal follicular dendritic cell sarcoma: a report of three cases and review of the literature. | Urun Y, Kankaya D, Koral L, Yalcin B, Karabork A, Ceyhan K, Boruban MC, Utkan G, Demirkazik A. | Tumori. 2013 Mar-Apr;99(2):e65-9. doi: 10.1177/030089161309900231. | 23748832 |
| Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members. | Urun Y, Akbulut H, Demirkazik A, Cay Senler F, Utkan G, Onur H, Icli F. | J BUON. 2013 Apr-Jun;18(2):511-5. | 23818370 |
| Association of ABO blood group and risk of lung cancer in a multicenter study in Turkey. | Urun Y, Utkan G, Cangir AK, Oksuzoglu OB, Ozdemir N, Oztuna DG, Kocaman G, Coşkun HŞ, Kaplan MA, Yuksel C, Demirkazik A, Icli F. | Asian Pac J Cancer Prev. 2013;14(5):2801-3. doi: 10.7314/apjcp.2013.14.5.2801. | 23803034 |
| Clinicopathological features of patients with malignant mesothelioma in a multicenter, case-control study: no role for ABO-Rh blood groups. | Utkan G, Ürün Y, Cangir AK, Kılıç D, Özdemir NY, Oztuna DG, Bulut E, Arslan ÜY, Koçer M, Kavukçu Ş, İçli F. | Asian Pac J Cancer Prev. 2013;14(1):249-53. | 23534732 |
| Topical aloe vera for the treatment of cetuximab-related acneiform rash in colorectal cancer: A case report. | Gürbüz M, Akkuş E, Utkan G. | J Oncol Pharm Pract. 2021 Mar;27(2):480-484. doi: 10.1177/1078155220937751. | 32623964 |
| ABO and Rh blood groups frequency in women with HER2 positive breast cancer. | Urun Y, Utkan G, Altundag K, Arslan O, Onur H, Arslan UY, Kocer M, Dogan I, Senler FC, Yalcin B, Demirkazik A, Akbulut H, Icli F. | J BUON. 2012 Jul-Sep;17(3):457-60. | 23033281 |
| Malign peritoneal mesothelioma with nephrotic syndrome. | Dogan M, Ozal G, Savas B, Gungor M, Utkan G, Yalcin B, Icli F. | Bratisl Lek Listy. 2012;113(1):43-5. doi: 10.4149/bll_2012_010. | 22380502 |
| Relationship between antimetabolite toxicity and pharmacogenetics in Turkish cancer patients. | Dogan M, Karabulut HG, Tukun A, Demirkazik A, Utkan G, Yalcin B, Dincol D, Akbulut H, Icli F. | Asian Pac J Cancer Prev. 2012;13(4):1553-6. doi: 10.7314/apjcp.2012.13.4.1553. | 22799365 |
| Retrospective analysis of seventy-one patients with neuroendocrine tumor and review of the literature. | Dogan M, Yalcin B, Ozdemir NY, Arslan UY, Dogan L, Utkan G, Akbulut H, Zengin N, Alkis N, Icli F. | Med Oncol. 2012 Sep;29(3):2021-6. doi: 10.1007/s12032-011-9986-9. | 21618056 |
| Lack of any relationship between ABO and Rh blood groups and clinicopathological features in patients with gastrointestinal stromal tumors: Turkish Oncology Group. | Urun Y, Utkan G, Şahin Ş, Coşkun HŞ, Koçer M, Özdemir NY, Kaplan MA, Arslan ÜY, Özdemir F, Öztuna D, Akbulut H, İçli F. | Asian Pac J Cancer Prev. 2012;13(8):4129-31. | 23098529 |
| ABO and Rh blood groups and risk of colorectal adenocarcinoma. | Urun Y, Utkan G, Ozdemir NY, Arslan UY, Savas B, Oksuzoglu B, Oztuna DG, Dogan I, Yalcin B, Senler FC, Onur H, Demirkazik A, Zengin N, Icli F. | Asian Pac J Cancer Prev. 2012;13(12):6097-100. doi: 10.7314/apjcp.2012.13.12.6097. | 23464411 |
| Is obesity always a risk factor for all breast cancer patients? c-erbB2 expression is significantly lower in obese patients with early stage breast cancer. | Mousa U, Onur H, Utkan G. | Clin Transl Oncol. 2012 Dec;14(12):923-30. doi: 10.1007/s12094-012-0878-z. | 22855166 |
| Kikuchi--Fujimoto disease: cervical lymphadenopathy suggestive of relapsing lymphoma in patient with lymphoblastic lymphoma. | Urun Y, Utkan G, Kankaya D, Dogan M, Yalcin B, İcli F. | Exp Oncol. 2011 Dec;33(4):242-4. | 22217716 |
| A rare gastric neoplasm: gastric medullary carcinoma. | Dogan M, Savas B, Utkan G, Bayar S, Ensari A, Icli F. | Med Oncol. 2011 Dec;28(4):945-7. doi: 10.1007/s12032-010-9557-5. | 20458556 |
| Optimal timing of adjuvant treatment in patients with early breast cancer. | Alkis N, Durnali AG, Arslan UY, Kocer M, Onder FO, Tokluoglu S, Celenkoglu G, Muallaoglu S, Utkan G, Ulas A, Altundag K. | Med Oncol. 2011 Dec;28(4):1255-9. doi: 10.1007/s12032-010-9566-4. | 20473647 |
| Fifty-one Kaposi sarcoma patients. | Dogan M, Dogan L, Ozdemir F, Ozdemir NY, Coskun HS, Arslan UY, Ozal G, Utkan G, Demirkazik A, Aydin F, Zengin N, Icli F. | Clin Transl Oncol. 2010 Sep;12(9):629-33. doi: 10.1007/s12094-010-0568-7. | 20851804 |
| | | |
| Two cases with atypical metastasis in colorectal cancer: splenic and renal metastasis. | Dogan M, Ozal G, Ekinci C, Utkan G, Urun Y, Yalcin B, Icli F. | Exp Oncol. 2010 Dec;32(4):277-9. | 21270761 |
| Activity of pemetrexed on brain metastases from non-small cell lung cancer: what is the mechanism? | Dogan M, Yalcin B, Utkan G, Urun Y, Ozal G. | Lung Cancer. 2009 Dec;66(3):399. doi: 10.1016/j.lungcan.2009.09.004. | 19783320 |
| Angiotensin-converting enzyme inhibitors: do they contribute to delayed chemotherapy induced nausea and vomiting? | Dogan M, Yalcin B, Ozal FG, Buyukcelik A, Utkan G, Icli F, Dogan L. | Med Hypotheses. 2009 Oct;73(4):628-9. doi: 10.1016/j.mehy.2009.06.028. | 19631476 |
| Lung cancer metastasis mimicking gluteal abscess. | Tek I, Iyidir OT, Utkan G, Ceyhan K, Buyukcelik A, Yalcin B, Demirkazik A. | South Med J. 2007 Mar;100(3):334-5. doi: 10.1097/SMJ.0b013e31802ffa07. | 17402150 |
| The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospective matched-paired study. | Dogan M, Demirkazik A, Konuk N, Yalcin B, Buyukcelik A, Utkan G, Tek I, Akbulut H, Sencan O, Icli F. | Int J Biol Markers. 2006 Oct-Dec;21(4):206-10. | 17177157 |
| Fine needle aspiration biopsy features with histologic correlation in mediastinal hepatoid yolk sac tumor presenting with sternum metastasis: a case report. | Ceyhan K, Utkan G, Dincol D, Erdogan N, Erekul S, Umudum H. | Acta Cytol. 2007 Jul-Aug;51(4):610-5. doi: 10.1159/000325809. | 17718136 |
| Alpha fetoprotein producing gastric hepatoid adenocarcinoma. | Utkan G, Büyükçelik A, Ceyhan K, Ortabozkoyun L, Tek I, Yalçin B, Dinçol D. | J Pak Med Assoc. 2006 Jun;56(6):292-4. | 16827258 |
| Extranodal Hodgkin disease presenting with gluteal mass and hypercalcemia. | Utkan G, Büyükçelik A, Yalçin B, Tek I, Doruk H, Dinçol D, Erekul S, Baykara M. | South Med J. 2006 Oct;99(10):1149-50. doi: 10.1097/01.smj.0000240720.24001.77. | 17100047 |
| Divided dose of cisplatin combined with gemcitabine in malignant mesothelioma. | Utkan G, Büyükçelik A, Yalçin B, Akbulut H, Demirkazık A, Dinçol D, Onur H, Gören D, Mousa U, Senler FC, İçli F. | Lung Cancer. 2006 Sep;53(3):367-74. doi: 10.1016/j.lungcan.2006.04.014. | 16828196 |
| Thrombosis of the pulmonary artery in a patient with mucinous adenocarcinoma. | Buyukcelik A, Bulent Y, Utkan G, Icli F, Sanlidilek U, Akbulut H. | Med Sci Monit. 2006 Sep;12(9):CS90-3. | 16940937 |
| Intracranial aggressive fibromatosis presenting as panhypopituitarism and diabetes insipidus. | Gursoy A, Cesur M, Aktaş B, Utkan G, Gedik VT, Erdogan M, Kamel N. | Pituitary. 2005;8(2):123-6. doi: 10.1007/s11102-005-3758-5. | 16379037 |
| Re: Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. | Yalcin B, Buyukcelik A, Yalcin S, Utkan G, Doruk H, Dogan M, Altan M. | J Natl Cancer Inst. 2005 Apr 6;97(7):542; author reply 542-3. doi: 10.1093/jnci/dji090. | 15812082 |
| Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma: is it safe? | Utkan G, Yalçin B, Büyükçelik A, Yalçin S. | J Clin Oncol. 2005 Jan 20;23(3):655; author reply 655. doi: 10.1200/JCO.2005.05.259. | 15659523 |
| Expression of p53 protein and DNA flow cytometry in gastric adenocarcinoma: implications in patients treated with adjuvant etoposide, adriamycin and cisplatin. | Büyükçelik A, Onur H, Akbulut H, Bülent Y, Ensari A, Utkan G, Onal BS, İçli F. | Tumori. 2005 Jul-Aug;91(4):302-8. doi: 10.1177/030089160509100403. | 16277093 |
| The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer. | Utkan G, Büyükçelik A, Yalçin B. | Ann Oncol. 2004 Oct;15(10):1574; author reply 1574-5. doi: 10.1093/annonc/mdh396. | 15367420 |
| Combination chemotherapy of gemcitabine and vinorelbine in patients with advanced non-small cell lung cancer. | Buyukcelik A, Utkan G, Yalcin B, Demirkazik A. | Lung Cancer. 2004 Dec;46(3):377-8. doi: 10.1016/j.lungcan.2004.03.024. | 15541824 |
| Blood viscosity in patients with diffuse large B cell non-Hodgkin's lymphoma. | Utkan G, Tek I, Kocer M, Muallaoglu S, Durnal AG, Arslan UY, Celenkoglu G, Tokluoglu S, Alkis N. | Exp Oncol. 2006 Dec;28(4):326-7. | 17285120 |
| Solid tumors in patients treated for Hodgkin's disease. | Utkan G, Büyükçelik A, Yalçin B. | Ann Oncol. 2004 Dec;15(12):1848-9. doi: 10.1093/annonc/mdh481. | 15550593 |
| Expression of Cox-2 protein in radioresistant laryngeal cancer. | Yalcin B, Büyükçelik A, Utkan G. | Ann Oncol. 2004 Nov;15(11):1721; author reply 1721-2. doi: 10.1093/annonc/mdh439. | 15520079 |
| Survival following the documentation of platinum and taxane resistance in ovarian cancer. | Büyükçelik A, Yalçin B, Utkan G, Doruk H. | Gynecol Oncol. 2004 Dec;95(3):774-5; author reply 775-6. doi: 10.1016/j.ygyno.2004.08.013. | 15582006 |
| Treatment of advanced head and neck cancer. | Yalçýn B, Büyükçelik A, Utkan G. | N Engl J Med. 2004 Aug 19;351(8):829-31; author reply 829-31. | 15320314 |
| Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincrine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. | Büyükçelik A, Yalçin B, Utkan G. | Cancer. 2004 Sep 1;101(5):1100-1; author reply 1101. doi: 10.1002/cncr.20461. | 15329922 |
| Adjuvant chemotherapy for lung cancer. | Büyükçelik A, Utkan G, Yalçin B. | N Engl J Med. 2004 Apr 15;350(16):1681-3; author reply 1681-3. | 15088318 |
| Multidisciplinary management of lung cancer. | Buyukcelik A, Yalcin B, Utkan G. | N Engl J Med. 2004 May 6;350(19):2008-10; author reply 2008-10. | 15131843 |
| Activity of irinotecan, cisplatin and dacarbazine (CPD) combination in previously treated patients with advanced colorectal carcinoma. | Akbulut H, Icli F, Yalcin B, Demirkazik A, Onur H, Buyukcelik A, Utkan G. | Exp Oncol. 2004 Jun;26(2):149-52. | 15273666 |
| High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas. | Yalcin B, Pamir A, Buyukcelik A, Utkan G, Akbulut H, Demirkazik A, Icli F. | Exp Oncol. 2004 Dec;26(4):320-5. | 15627067 |
| Post-transfusion acute graft versus host disease in a 17-year-old girl with a malignant mesenchymal tumor--report of a case. | Utkan G, Buyukcelik A, Demir O, Sanli H, Pamir A. | Acta Med Austriaca. 2003;30(5):138-41. | 15055161 |
| Non-Hodgkin's lymphoma of the female urethra presenting as a caruncle. | Atalay AC, Karaman MI, Basak T, Utkan G, Ergenekon E. | Int Urol Nephrol. 1998;30(5):609-10. doi: 10.1007/BF02550554. | 9934806 |
| Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer. | Yazici O, Dogan M, Ozal G, Aktas SH, Demirkazik A, Utkan G, Senler FC, Icli F, Akbulut H. | Comb Chem High Throughput Screen. 2021;24(8):1229-1235. doi: 10.2174/1386207323666200902135349. | |
| Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer. | Icli F, Akbulut H, Utkan G, Yalcin B, Dincol D, Isikdogan A, Demirkazik A, Onur H, Cay F, Büyükcelik A. | J Surg Oncol. 2007 May 1;95(6):507-12. doi: 10.1002/jso.20728. | 32881660 |
